The effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome

dc.contributor.authorAbiad, Firass
dc.contributor.authorKhalife, Dalia
dc.contributor.authorSafadi, Bassem Y.
dc.contributor.authorAlami, Ramzi S.
dc.contributor.authorAwwad, Johnny T.
dc.contributor.authorKhalifeh, Fatin
dc.contributor.authorGhazeeri, Ghina S.
dc.contributor.departmentSurgery
dc.contributor.departmentObstetrics and Gynecology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:12:50Z
dc.date.available2025-01-24T12:12:50Z
dc.date.issued2018
dc.description.abstractAim: The aims of this study is to address the improvement in CRP and adiponectin in obese PCOS and non PCOS after bariatric surgery, and to show that obese PCOS women have a slower rate of improvement when compared to obese non PCOS women. Methods: This is a prospective case-control study evaluating the effect of weight loss by sleeve gastrectomy among obese PCOS patients. Results: There was a 36.28% of weight loss among obese PCOS and 33.04% among the control group at 12 months. Both groups showed a significant increase in the adiponectin levels at 3, 6 and 12 months’ post-surgery. The rate of increase was higher in the obese non PCOS women (4.93 ± 1.79–9.79 ± 3.9) compared to obese PCOS women (5.05 ± 1.98–7.25 ± 0.21). The CRP levels decreased with weight loss after the surgery to reach statistical significance at 3 months in obese PCOS group (4.18 ± 3.94, p = 0.048). Conclusion: The degree of weight loss after surgery was effective in lowering CRP and increasing adiponectin levels in PCOS women. However, this improvement was slower compared to obese non PCOS patients. A genetic predisposition to insulin resistance might explain these findings. © 2018 Diabetes India
dc.identifier.doihttps://doi.org/10.1016/j.dsx.2018.06.013
dc.identifier.eid2-s2.0-85049305694
dc.identifier.pmid30168430
dc.identifier.urihttp://hdl.handle.net/10938/32897
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofDiabetes and Metabolic Syndrome: Clinical Research and Reviews
dc.sourceScopus
dc.subjectInflammatory markers
dc.subjectPolycystic ovary syndrome
dc.subjectSleeve gastrectomy
dc.subjectAdiponectin
dc.subjectAdult
dc.subjectAnthropometry
dc.subjectBariatric surgery
dc.subjectBiomarkers
dc.subjectBody composition
dc.subjectC-reactive protein
dc.subjectCase-control studies
dc.subjectFemale
dc.subjectHumans
dc.subjectInsulin
dc.subjectObesity
dc.subjectProspective studies
dc.subjectSex hormone-binding globulin
dc.subjectTestosterone
dc.subjectWeight loss
dc.subjectYoung adult
dc.subjectC reactive protein
dc.subjectGlucose
dc.subjectHigh density lipoprotein cholesterol
dc.subjectLow density lipoprotein cholesterol
dc.subjectSex hormone binding globulin
dc.subjectTriacylglycerol
dc.subjectBiological marker
dc.subjectArticle
dc.subjectBody weight loss
dc.subjectCase control study
dc.subjectControlled study
dc.subjectHirsutism
dc.subjectHuman
dc.subjectInsulin level
dc.subjectMajor clinical study
dc.subjectOvary polycystic disease
dc.subjectPriority journal
dc.subjectProspective study
dc.subjectBlood
dc.subjectComplication
dc.subjectMetabolism
dc.titleThe effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-7963.pdf
Size:
508.47 KB
Format:
Adobe Portable Document Format